Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 17, 2024

BUY
$31.86 - $67.26 $63,720 - $134,520
2,000 New
2,000 $86,000
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $39.3 Million - $83 Million
-1,233,282 Reduced 99.84%
2,000 $86,000
Q1 2023

May 17, 2024

BUY
$45.44 - $74.26 $55.9 Million - $91.4 Million
1,231,282 Added 30782.05%
1,235,282 $81.2 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $55.9 Million - $91.4 Million
1,231,282 Added 30782.05%
1,235,282 $81.2 Million
Q4 2022

May 17, 2024

BUY
$41.39 - $81.0 $165,560 - $324,000
4,000 New
4,000 $179,000
Q4 2022

Feb 14, 2023

SELL
$41.39 - $81.0 $244,739 - $478,953
-5,913 Reduced 59.65%
4,000 $179,000
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $7.16 Million - $9.37 Million
-82,132 Reduced 89.23%
9,913 $1.06 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $1.4 Million - $1.85 Million
14,900 Added 19.31%
92,045 $10.2 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $8.22 Million - $9.56 Million
68,738 Added 817.63%
77,145 $9.91 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $966,045 - $1.26 Million
-8,849 Reduced 51.28%
8,407 $1.12 Million
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $731,679 - $843,611
-7,292 Reduced 29.71%
17,256 $1.87 Million
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $1.54 Million - $1.91 Million
15,217 Added 163.08%
24,548 $2.59 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $676,305 - $829,710
7,875 Added 540.87%
9,331 $963,000
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $105,909 - $134,680
1,456 New
1,456 $125,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.